- Home
- MDGL vs FHN Comparison
MDGL vs FHN Comparison
Compare MDGL & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDGL | FHN |
|---|---|---|
| Founded | 2011 | 1864 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 11.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDGL | FHN |
|---|---|---|
| Price | $561.08 | $23.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 20 |
| Target Price | ★ $553.08 | $24.20 |
| AVG Volume (30 Days) | 317.0K | ★ 5.7M |
| Earning Date | 11-04-2025 | 01-15-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | N/A | ★ 20.88 |
| EPS | N/A | ★ 1.65 |
| Revenue | $740,640,000.00 | ★ $3,184,000,000.00 |
| Revenue This Year | $436.04 | $12.70 |
| Revenue Next Year | $53.17 | $2.54 |
| P/E Ratio | ★ N/A | $14.25 |
| Revenue Growth | ★ 864.21 | 3.68 |
| 52 Week Low | $265.00 | $15.19 |
| 52 Week High | $605.00 | $24.11 |
Technical Indicators
Market Signals| Indicator | MDGL | FHN |
|---|---|---|
| Relative Strength Index (RSI) | 55.21 | 67.70 |
| Support Level | $546.20 | $22.63 |
| Resistance Level | $589.67 | $24.11 |
| Average True Range (ATR) | 20.09 | 0.46 |
| MACD | -6.52 | 0.15 |
| Stochastic Oscillator | 24.57 | 84.12 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.